1. Home
  2. NBIX vs KSPI Comparison

NBIX vs KSPI Comparison

Compare NBIX & KSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • KSPI
  • Stock Information
  • Founded
  • NBIX 1992
  • KSPI 2008
  • Country
  • NBIX United States
  • KSPI Kazakhstan
  • Employees
  • NBIX N/A
  • KSPI N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • KSPI
  • Sector
  • NBIX Health Care
  • KSPI
  • Exchange
  • NBIX Nasdaq
  • KSPI Nasdaq
  • Market Cap
  • NBIX 13.2B
  • KSPI 15.7B
  • IPO Year
  • NBIX 1996
  • KSPI 2024
  • Fundamental
  • Price
  • NBIX $128.91
  • KSPI $76.16
  • Analyst Decision
  • NBIX Strong Buy
  • KSPI Strong Buy
  • Analyst Count
  • NBIX 22
  • KSPI 3
  • Target Price
  • NBIX $165.59
  • KSPI $135.67
  • AVG Volume (30 Days)
  • NBIX 935.9K
  • KSPI 289.4K
  • Earning Date
  • NBIX 07-30-2025
  • KSPI 08-04-2025
  • Dividend Yield
  • NBIX N/A
  • KSPI 4.57%
  • EPS Growth
  • NBIX 2.97
  • KSPI 21.00
  • EPS
  • NBIX 3.39
  • KSPI 11.10
  • Revenue
  • NBIX $2,509,900,000.00
  • KSPI $5,558,665,401.00
  • Revenue This Year
  • NBIX $16.12
  • KSPI $23.67
  • Revenue Next Year
  • NBIX $15.06
  • KSPI $20.73
  • P/E Ratio
  • NBIX $38.04
  • KSPI $6.88
  • Revenue Growth
  • NBIX 18.42
  • KSPI 36.00
  • 52 Week Low
  • NBIX $84.23
  • KSPI $76.28
  • 52 Week High
  • NBIX $157.98
  • KSPI $131.62
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 46.34
  • KSPI 32.05
  • Support Level
  • NBIX $130.75
  • KSPI $86.52
  • Resistance Level
  • NBIX $137.44
  • KSPI $87.26
  • Average True Range (ATR)
  • NBIX 3.60
  • KSPI 2.75
  • MACD
  • NBIX -0.71
  • KSPI -0.94
  • Stochastic Oscillator
  • NBIX 33.88
  • KSPI 1.86

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

About KSPI Joint Stock Company Kaspi.kz

Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform that connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.

Share on Social Networks: